ロード中...
α‐Emitting cancer therapy using (211)At‐AAMT targeting LAT1
α‐Methyl‐l‐tyrosine (AMT) has a high affinity for the cancer‐specific l‐type amino acid transporter 1 (LAT1). Therefore, we established an anti‐cancer therapy, with (211)At‐labeled α‐methyl‐l‐tyrosine ((211)At‐AAMT) as a carrier of (211)At into tumors. (211)At‐AAMT had high affinity for LAT1, inhibi...
保存先:
| 出版年: | Cancer Sci |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7935802/ https://ncbi.nlm.nih.gov/pubmed/33277750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14761 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|